[2023]Effective-compounds of Jinshui Huanxian formula ameliorates fibroblast activation in pulmonary fibrosis by inhibiting the activation of mTOR signaling

上一条：[2023]Targeting biophysical microenvironment for improved treatment of chronic obstructive pulmonary disease

下一条：[2023]Add-on Chinese medicine for hospitalized chronic obstructive pulmonary disease (CHOP): A cohort study of hospital registry

【关闭】